Compliance With Medication Regimens for Mental and Physical Disorders

Cramer JA: Partial medication compliance: the enigma in poor medical outcomes. American Journal of Managed Care 1:45- 52, 1995

Rudd P, Bynny RL, Zachary V, et al: Pill count measures of compliance in a drug trial: variability and suitability. American Journal of Hypertension 1:309-312, 1988

Pullar T, Birtwell AJ, Wiles PG, et al: Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clinical Pharmacology and Therapeutics 44:545- 545, 1988

Cramer JA: Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49:321-327, 1995

Cramer JA, Mattson RH, Prevey ML, et al: How often is medication taken as prescribed? A novel assessment technique. JAMA 261:3273-3277, 1989

Adams SG, Howe JT: Predicting medication compliance in a psychiatric population. Journal of Nervous and Mental Disease 181:558-560, 1993

Herz MI, Melville C: Relapse in schizophrenia. American Journal of Psychiatry 137:801-805, 1980

Hogarty GE, Goldberg SC, Collaborative Study Group: Drug and sociopathy in the aftercare of schizophrenic patients: one-year relapse rates. Archives of General Psychiatry 28:54-64, 1973

Kelley GR, Scott JE: Medication compliance and health education among outpatients with chronic mental disorders. Medical Care 28:1181-1197, 1990

Michaux WW: Side effects, resistance, and dosage deviations in psychiatric outpatients treated with tranquilizers. Journal of Nervous and Mental Disease 133:203-212, 1961

Parkes CM, Brown GW, Monck EM: The general practitioner and the schizophrenic patient. British Medical Journal 2:972-976, 1962

Pollack B: The effect of chlorpromazine in reducing the relapse rate in 716 released patients: study 3. American Journal of Psychiatry 114:749-751, 1958

Reilly EL, Wilson WP, McClinton HK: Clinical characteristics and medication history of schizophrenics readmitted to the hospital. International Journal of Neuropsychiatry 3:85-90, 1967

Renton CA, Affleck JW, Carstairs GM, et al: A follow-up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39:548-600, 1963

Serban G, Thomas A: Attitudes and behaviors of acute and chronic schizophrenic patients regarding ambulatory treatment. American Journal of Psychiatry 131:991- 995, 1974

Van Putten T: Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31:67-72, 1974

Wolff RJ, Colacino DM: A preliminary report on the continued post-hospital use of tranquilizing drugs. American Journal of Psychiatry 118:499-503, 1961

Buchanan A: A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine 22:787-797, 1992

Fleishhacker WW, Meise U, Gunther V, et al: Compliance with antipsychotic drug treatment: influence of side effects. Acta Psychiatrica Scandinavica 89 (suppl 382):11-15, 1994

Leff JP, Wing JK: Trial of maintenance therapy in schizophrenia. British Medical Journal 3:599-604, 1971

Quitkin F, Rifkin A, Kane J, et al: Long- acting oral vs injectable antipsychotic drugs in schizophrenics. Archives of General Psychiatry 35:889-892, 1978

Raskin A: A comparison of acceptors and resistors of drug treatment as an adjunct to psychotherapy. Journal of Consulting and Clinical Psychology 25:366, 1961

Carman JS, Wyatt ES, Fleck R, et al: Neuroleptic compliance in schizophrenic outpatients. Psychiatric Hospitals 15:173-178, 1984

Falloon I, Watt DC, Shepherd M: A comparative controlled trial of pimozide and fluphenazine decanoate in the continued therapy of schizophrenia. Psychological Medicine 8:59-70, 1978

Irwin DS, Weitzel WD, Morgan DW: Phenothiazine intake and staff attitudes. American Journal of Psychiatry 127:1631-1635, 1971

Kapur S, Ganguli R, Ulrich R, et al: Use of random sequence riboflavin as a marker of medication compliance in chronic schizophrenics. Schizophrenia Research 6:49-53, 1992

Mason AS, Forrest IS, Forrest FW, et al: Adherence to maintenance therapy and rehospitalization. Diseases of the Nervous System 24:103-104, 1963

McClellan TA, Cowan G: Use of antipsychotic and antidepressant drugs by chronically ill patients. American Journal of Psychiatry 126:1771-1773, 1970

Willcox DRC, Gillan R: Do psychiatric out-patients take their drugs? British Medical Journal 2:790-792, 1965

Myers ED, Calvert EJ: Information, compliance, and side-effects: a study of patients on antidepressant medication. British Journal of Clinical Pharmacology 17:21-25, 1984

Myers ED, Branthwaite A: Out-patient compliance with antidepressant medication. British Journal of Psychiatry 160:83- 86, 1992

Connelly CE, Davenport YB, Nurnberger JT: Adherence to treatment regimen in a lithium carbonate clinic. Archives of General Psychiatry 39:585-588, 1982

Lipman RS, Rickels K, Uhlenhuth EH, et al: Neurotics who fail to take their drugs. British Journal of Psychiatry 111:1043- 1049, 1965

Frank JD, Gliedman LH, Imber SD, et al: Why patients leave psychotherapy. Archives of Neurology and Psychiatry 77:283-299, 1957

Ayd FJ: Single daily dose of antidepressants. JAMA 230:263-264, 1974

Lee S: The prevalence and nature of lithium noncompliance among Chinese psychiatric patients in Hong Kong. Journal of Nervous and Mental Disease 181:618-625, 1993

Maddox JC, Levi M, Thompson C: The compliance with antidepressants in general practice. Journal of Psychopharmacology 8:48-53, 1994

Montgomery SA, Kasper S: Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology 9(suppl 4):33-40, 1995

Kass MA, Meltzer DW, Gordon M, et al: Compliance with topical pilocarpine treatment. American Journal of Ophthalmology 101:515-523, 1986

Kruse W, Rampmaier J, Ullrich G, et al: Patterns of drug compliance with medications to be taken once or twice daily assessed by continuous electronic monitoring in primary care. International Journal of Clinical Pharmacology and Therapeutics 32:452-457, 1994

Kruse W, Eggert-Kruse W, Rampmaier J, et al: Dosage frequency and drug compliance behavior: a comparative study on compliance with a medication to be taken twice or four times daily. European Journal of Clinical Pharmacology 41:589-592, 1991

Kruse W, Nikolaus T, Rampmaier J, et al: Actual versus prescribed timing of lovastatin doses assessed by electronic compliance monitoring. European Journal of Clinical Pharmacology 45:211-215, 1993

Kruse W, Weber E: Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. European Journal of Clinical Pharmacology 38:561- 565, 1990

Mengden T, Binswanger B, Spuhler T, et al: The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amplodipine once a day, morning versus evening. Journal of Hypertension 11:1403-1411, 1993

Nides MA, Tashkin DP, Simmons MS, et al: Improving inhaler adherence in a clinical trial through the use of the Nebulizer Chronolog. Chest 104:501-507, 1993

Olivieri NF, Matsui D, Hermann C, et al: Compliance assessed by the Medication Event Monitoring System. Archives of Diseases in Childhood 66:1399-1402, 1991

Straka RJ, Fish JT, Benson SR, et al: Magnitude and nature of noncompliance with treatment using isosorbide dinitrate in patients with ischemic heart disease. Journal of Clinical Pharmacology 36:587-594, 1996

Waterhouse DM, Calzone KA, Mele C, et al: Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. Journal of Clinical Oncology 11:1189-1197, 1993

Blackwell B: From compliance to alliance: a quarter century of research. Netherlands Journal of Medicine 48:140-149, 1996

Salem RB, Keane TM, Williams JG: Drug related admissions to a Veterans Administration psychiatric unit. Drug Intelligence and Clinical Pharmacology 18:74-76, 1984

Sullivan G, Wells KB, Morgenstern H, et al: Identifying modifiable risk factors for rehospitalization: a case-control study of seriously mentally ill persons in Mississippi. American Journal of Psychiatry 152:1749- 1756, 1995

Razali MS, Yaha H: Compliance with treatment in schizophrenia: a drug intervention program in a developing country. Acta Psychiatrica Scandinavica 91:331-335, 1995

Cramer JA, Scheyer R, Mattson R: Compliance declines between clinic visits. Archives of Internal Medicine 150:1509- 1510, 1990

Farmer KC, Jacobs EW, Phillips CR: Long-term patient compliance with prescribed regimens of calcium channel blockers. Clinical Therapeutics 16:316-326, 1994

Urquhart J: Variable patient compliance in ambulatory trials: nuisance, threat, opportunity. Journal of Antimicrobial Chemotherapy 32:643-649, 1993